Efficacy and Safety of Ublituximab vs Teriflunomide in Patients with Relapsing Multiple Sclerosis: Results from Two Phase 3 Studies ULTIMATE I & ULTIMATE II American Academy of Neurology

Drug Category : Array
Conference Category : Array
Lead Author : Steinman L, et al.
Published Date : 17/04/2021
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2021/04/ULTIMATE-I-II-Phase-3-Poster-AAN-2021.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top